Is the elimination of endotoxin and cytokines with continuous lavage an alternative procedure in necrotizing enterocolitis?

Acta Pædiatrica

Volumn 83, Issue , 1994, Pages 24-26

  Birk, D ^a   Berger, D ^a   Limmer, J ^a   Beger, HG ^a  

^a Department of Biomaterials   (Germany)

Author keywords

Cytokines; endotoxin; intraperitoneal lavage; necrotizing enterocolitis

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ASCITES; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; MALE; NECROTIZING ENTERITIS; NEWBORN; PERITONEUM LAVAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MICROBIOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PSEUDOMEMBRANOUS COLITIS; SURVIVAL RATE; TREATMENT OUTCOME;

ASCITES; COMBINED MODALITY THERAPY; CYTOKINES; ENDOTOXINS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT, NEWBORN; INTERLEUKIN-1; INTERLEUKIN-6; MALE; PERITONEAL LAVAGE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR;

EID: 0028186816     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1994.tb13237.x     Document Type: Article

References (13)

1. Neonatal necrotizing enterocolitis: an update on etiology, diagnosis and treatment
2. Treatment for necrotizing enterocolitis perforation in the extremely premature infant
3. Models of the pathogenesis of necrotizing enterocolitis
4. Unique characteristics of neonatal intestinal mucosal barrier
5. The effect of E. coli virulence on bacterial translocation and systemic sepsis in the neonatal rabbit model
6. Endotoxin binding proteins of human serum: are there therapeutical implications
7. Paracentesis and lavage for diagnosis of intestinal gangrene in neonatal necrotizing enterocolitis
8. Prevention and treatment of necrotizing enterocolitis in the newborn: paediatric aspects
9. Treatment of gram negative bacteremia and septic shock with HA‐1A human monoclonal antibodies against endotoxin. A randomized, double‐blind, placebo–controlled study
10. Association between protective effiacy of antilipo‐polysaccharide (LPS) and suppression of LPS‐induced tumor necrosis factor alpha and interleukin 6. Comparison of O side‐chain specific antibodies with core LPS antibodies
11. Endotoxin, TNF alpha Interleukin‐6 and parameters of the cellular immune system in patients with intra‐abdominal sepsis
12. Plasma tumor necrosis factor levels in patients with presumed sepsis